Healthcare provider profile · identity verified

Christopher J Perkins, MD

Internal Medicine · NORWOOD, MA · NPI 1669479622

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	578	143
Lisinopril	Lisinopril	509	122
Amlodipine Besylate	Amlodipine Besylate	379	90
Metoprolol Succinate	Metoprolol Succinate	342	78
Omeprazole	Omeprazole	318	91
Simvastatin	Simvastatin	310	85
Levothyroxine Sodium	Levothyroxine Sodium	291	67
Losartan Potassium	Losartan Potassium	219	50
Pantoprazole Sodium	Pantoprazole Sodium	198	35
Metformin Hcl	Metformin Hcl	196	51
Trazodone Hcl	Trazodone Hcl	191	30
Furosemide	Furosemide	190	47
Lorazepam	Lorazepam	185	44
Hydrochlorothiazide	Hydrochlorothiazide	173	49
Rosuvastatin Calcium	Rosuvastatin Calcium	171	33
Eliquis	Apixaban	157	30
Allopurinol	Allopurinol	142	38
Donepezil Hcl	Donepezil Hcl	141	13
Gabapentin	Gabapentin	133	31
Mirtazapine	Mirtazapine	123	32
Escitalopram Oxalate	Escitalopram Oxalate	119	15
Atenolol	Atenolol	108	31
Glipizide	Glipizide	108	24
Jardiance	Empagliflozin	102	19
Albuterol Sulfate Hfa	Albuterol Sulfate	93	35
Tamsulosin Hcl	Tamsulosin Hcl	92	23
Warfarin Sodium	Warfarin Sodium	90	15
Pravastatin Sodium	Pravastatin Sodium	87	21
Metoprolol Tartrate	Metoprolol Tartrate	85	26
Clopidogrel	Clopidogrel Bisulfate	83	13
Quetiapine Fumarate	Quetiapine Fumarate	82	suppressed
Sertraline Hcl	Sertraline Hcl	79	17
Alendronate Sodium	Alendronate Sodium	76	20
Famotidine	Famotidine	73	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	70	suppressed
Potassium Chloride	Potassium Chloride	68	suppressed
Alprazolam	Alprazolam	65	12
Gemfibrozil	Gemfibrozil	59	suppressed
Propranolol Hcl Er	Propranolol Hcl	56	suppressed
Paroxetine Hcl	Paroxetine Hcl	53	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	13
Bupropion Xl	Bupropion Hcl	49	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	49	suppressed
Prednisone	Prednisone	49	35
Citalopram Hbr	Citalopram Hydrobromide	48	13
Fluticasone Propionate	Fluticasone Propionate	48	24
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	47	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	44	suppressed
Hydralazine Hcl	Hydralazine Hcl	44	suppressed
Tramadol Hcl	Tramadol Hcl	44	11
Oxycodone Hcl	Oxycodone Hcl	42	11
Finasteride	Finasteride	39	suppressed
Glipizide Er	Glipizide	39	suppressed
Ozempic	Semaglutide	38	suppressed
Ezetimibe	Ezetimibe	37	suppressed
Carvedilol	Carvedilol	35	suppressed
Irbesartan	Irbesartan	35	suppressed
Synthroid	Levothyroxine Sodium	35	11
Ketoconazole	Ketoconazole	31	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Lovastatin	Lovastatin	31	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Clonazepam	Clonazepam	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	26	11
Memantine Hcl	Memantine Hcl	26	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Xifaxan	Rifaximin	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	20
Ursodiol	Ursodiol	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Mounjaro	Tirzepatide	22	suppressed
Torsemide	Torsemide	22	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Colchicine	Colchicine	20	13
Duloxetine Hcl	Duloxetine Hcl	20	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	12
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	17
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Imipramine Hcl	Imipramine Hcl	17	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Cephalexin	Cephalexin	15	13
Mometasone Furoate	Mometasone Furoate	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Tiadylt Er	Diltiazem Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Methimazole	Methimazole	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Azithromycin	Azithromycin	13	13
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Gemtesa	Vibegron	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Valsartan	Valsartan	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Digoxin	Digoxin	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error